Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
VTL > SEC Filings for VTL > Form 8-K on 9-Jul-2014All Recent SEC Filings

Show all filings for VITAL THERAPIES INC



Other Events, Financial Statements and Exhibits

Item 8.01. Other Information.

On July 9, 2014, Vital Therapies, Inc. issued a press release providing an update on the status of its clinical trials of ELADŽ, a cell-based therapy targeting treatment of acute liver failure, and on advice received from the European Medical Agency through the Scientific Advice Working Party process. As a part of this update, Vital Therapies, Inc. reported enrollment of 123 subjects in its VTI-208 Phase 3 randomized, controlled clinical trial targeting 200 subjects with alcohol-induced liver decompensation, or AILD. A copy of this press release is attached hereto as Exhibit 99.1.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No. Description

99.1 Press Release dated July 9, 2014, of the registrant.

  Add VTL to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for VTL - All Recent SEC Filings
Copyright © 2015 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.